New approach repairs airway barrier defects in cystic fibrosis
A UNIGE team has succeeded in restoring the defective respiratory protective barrier in people with this rare genetic…
Using DNA sequencing for accurate identification of microbial infections in cystic fibrosis patients
Lung infections are a constant risk for people living with cystic fibrosis (CF), a life-threatening genetic disorder which…
Colorado can’t cap price of arthritis drug Enbrel, judge rules
Colorado can’t cap the price of arthritis medication Enbrel while a lawsuit challenging the state’s drug affordability board’s…
Cystic Fibrosis Care Still Below Pre-Pandemic Levels
New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019…
A Loophole Brings Cystic Fibrosis Patients a ‘Miracle Drug’ in Generic Form
Josua Lottering stepped out the airport doors in the Bangladesh capital, Dhaka, and doubled over in coughing spasms.…
Early lung damage patterns uncovered in children with cystic fibrosis
Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights…
New mechanism disables antibiotic resistance and cross-protection in bacteria
A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance and a process known…
Advancing Gene Therapy for Cystic Fibrosis
Original story from University of California, Los Angeles (UCLA; CA, USA). UCLA researchers have developed a lipid nanoparticle-based…
Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Flu wave’s hidden cost on people with cystic fibrosis
People with cystic fibrosis (CF) are uniquely vulnerable to the flu wave currently ripping through the UK, a…
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve…
New biofilm discovery may pave way to undermining antibiotic-resistant Pseudomonas
The bacterium known as Pseudomonas aeruginosa is an unwelcome visitor in the human body. Serious infections can result…